Zakup i sukcesywna dostawa leków onkologicznych oraz leków różnych.
12 suppliers awarded•31 lots awarded•€16.90M awarded
Buyer: Uniwersytecki Szpital Kliniczny im. Fryderyka Chopina w Rzeszowie / Rzeszów, Poland
Awarded value
€16.90M
Estimated value
€16.90M
Awarded at 100% of estimated value
Award date
Jul 20, 2026
Winners
12
Lots awarded
31
Winners
Wrocław, POL
€9.0M This contract
163 award notices•427 awarded lots•€249.13M total
Poznań, POL
€2.5M This contract
18 award notices•19 awarded lots•€21.08M total
Poznań, POL
€2.5M This contract
54 award notices•151 awarded lots•€13.81M total
Warszawa, POL
€2.4M This contract
14 award notices•21 awarded lots•€14.76M total
Warszawa, POL
€2.1M This contract
137 award notices•196 awarded lots•€47.71M total
Wrocław, POL
€307,219 This contract
88 award notices•229 awarded lots•€41.51M total
Warszawa, POL
€244,028 This contract
32 award notices•54 awarded lots•€3.46M total
Warszawa, POL
€244,028 This contract
37 award notices•69 awarded lots•€65.25M total
Warszawa, POL
€86,067 This contract
63 award notices•119 awarded lots•€13.26M total
Warszawa, POL
€25,869 This contract
30 award notices•74 awarded lots•€8.62M total
Lots awarded
| Lot | Title | Winner | Award value | Main CPV |
|---|---|---|---|---|
| LOT-0027 | URTICA Sp. z o.o. | €8.5M | Antineoplastic agents (33652100) | |
| LOT-0005 | GSK SERVICES SP. Z O.O. | €2.5M | Antineoplastic agents (33652100), Pharmaceutical products (33600000) | |
| LOT-0020 | Abbvie Sp. z o.o. | €2.4M | Antineoplastic agents (33652100) | |
| LOT-0031 | Takeda Pharma Sp. z o.o. | €2.1M | Antineoplastic agents (33652100) | |
| LOT-0024 | URTICA Sp. z o.o. | €372,282 | Antineoplastic agents (33652100) | |
| LOT-0019 | CENTRALA FARMACEUTYCZNA CEFARM SA | €143,398 | Antineoplastic agents (33652100) | |
| LOT-0001 | CENTRALA FARMACEUTYCZNA CEFARM SA | €100,630 | Antineoplastic agents (33652100), Pharmaceutical products (33600000) | |
| LOT-0022 | CSL Behring Sp. z o.o. | €86,067 | Antineoplastic agents (33652100) | |
| LOT-0026 | URTICA Sp. z o.o. | €83,213 | Antineoplastic agents (33652100) | |
| LOT-0017 | Asclepios S.A. | €78,162 | Antineoplastic agents (33652100) | |
| LOT-0013 | Asclepios S.A. | €57,048 | Antineoplastic agents (33652100) | |
| LOT-0011 | URTICA Sp. z o.o. | €39,937 | Antineoplastic agents (33652100) | |
| LOT-0029 | Asclepios S.A. | €39,809 | Antineoplastic agents (33652100) | |
| LOT-0021 | GSK Services Sp. z o.o. | €38,521 | Antineoplastic agents (33652100) | |
| LOT-0002 | AstraZeneca Kft | €37,018 | Antineoplastic agents (33652100), Pharmaceutical products (33600000) | |
| LOT-0009 | LEK S.A. | €34,422 | Antineoplastic agents (33652100), Pharmaceutical products (33600000) | |
| LOT-0008 | Asclepios S.A. | €34,218 | Antineoplastic agents (33652100), Pharmaceutical products (33600000) | |
| LOT-0003 | Asclepios S.A. | €31,514 | Antineoplastic agents (33652100), Pharmaceutical products (33600000) | |
| LOT-0025 | Asclepios S.A. | €26,212 | Antineoplastic agents (33652100) | |
| LOT-0028 | Fresenius Kabi Polska Sp. z o.o. | €25,869 | Antineoplastic agents (33652100) | |
| LOT-0012 | Asclepios S.A. | €25,005 | Antineoplastic agents (33652100) | |
| LOT-0010 | LEK S.A. | €17,211 | Antineoplastic agents (33652100) | |
| LOT-0014 | GSK Services Sp. z o.o. | €6,051 | Antineoplastic agents (33652100) | |
| LOT-0006 | GSK Services Sp. z o.o. | €5,872 | Antineoplastic agents (33652100), Pharmaceutical products (33600000) | |
| LOT-0023 | Asclepios S.A. | €5,198 | Antineoplastic agents (33652100) | |
| LOT-0030 | Asclepios S.A. | €4,423 | Antineoplastic agents (33652100) | |
| LOT-0018 | Asclepios S.A. | €4,142 | Antineoplastic agents (33652100) | |
| LOT-0007 | Asclepios S.A. | €1,488 | Antineoplastic agents (33652100), Pharmaceutical products (33600000) | |
| LOT-0004 | Not specified | — | Antineoplastic agents (33652100), Pharmaceutical products (33600000) | |
| LOT-0015 | Not specified | — | Antineoplastic agents (33652100) | |
| LOT-0016 | Not specified | — | Antineoplastic agents (33652100) |